trial,pubID,pseudogroup,weeks,group,IgD-/IgM-/IgA-/IgG+/KO-/Antigen++ B cells
G002,G002-852,G002,8,1,4534.0
G002,G002-616,G002,8,1,6688.0
G002,G002-931,G002,8,3,4106.0
G002,G002-577,G002,8,2,4800.0
G002,G002-493,G002,8,2,3841.0
G002,G002-119,G002,8,2,3274.0
G002,G002-758,G002,8,1,2882.0
G002,G002-831,G002,8,2,4190.0
G002,G002-502,G002,8,1,4892.0
G002,G002-293,G002,8,2,3776.0
G002,G002-943,G002,8,2,4327.0
G002,G002-630,G002,8,2,2833.0
G002,G002-136,G002,8,2,2395.0
G002,G002-341,G002,8,2,2779.0
G002,G002-145,G002,8,2,2479.0
G002,G002-371,G002,8,3,2594.0
G002,G002-820,G002,8,2,3870.0
G002,G002-997,G002,8,3,2580.0
G002,G002-509,G002,8,1,3157.0
G002,G002-813,G002,8,1,1229.0
G002,G002-988,G002,8,3,3544.0
G002,G002-619,G002,8,1,4957.0
G002,G002-905,G002,8,1,2129.0
G002,G002-304,G002,8,3,1449.0
G002,G002-546,G002,8,1,1993.0
G002,G002-855,G002,8,2,1734.0
G002,G002-516,G002,8,1,1229.0
G002,G002-477,G002,8,3,1787.0
G002,G002-678,G002,8,1,1316.0
G002,G002-884,G002,8,3,1271.0
G002,G002-230,G002,8,2,16382.0
G002,G002-796,G002,8,3,4037.0
G002,G002-620,G002,8,2,855.0
G002,G002-595,G002,8,3,650.0
G002,G002-866,G002,8,3,583.0
G002,G002-733,G002,8,1,2954.0
G002,G002-871,G002,8,3,716.0
G002,G002-834,G002,8,1,1401.0
G002,G002-969,G002,8,1,1271.0
G002,G002-810,G002,8,3,707.0
G002,G002-427,G002,8,3,388.0
G002,G002-957,G002,8,2,1821.0
G002,G002-479,G002,8,1,2323.0
G002,G002-302,G002,8,1,1409.0
G002,G002-632,G002,8,3,169.0
G002,G002-947,G002,8,2,490.0
G002,G002-480,G002,8,2,414.0
G002,G002-462,G002,8,3,146.0
G002,G002-278,G002,8,3,1016.0
